Original Research Article I Volume 5 I Issue 2 I 2017

Plasma beta2 microglobulin as a marker of progression in chronic Kidney disease patients

Rania Mohamed Farag, Hanaa Mahmoud Ali, Heba Seleem El-Shair and Salah Saaed Naga

Biolife. 5(1), pp 28-32

DOI:https://doi.org/10.5281/zenodo.7356471

Abstract:

Chronic kidney disease (CKD) is a world-wide public health problem with adverse outcomes of kidney failure. Early diagnosis and treatment may delay or even prevent the onset of nephropathy in CKD. The measurement of glomerular filtration rate (GFR) is the gold standard for the assessment of renal function. Beta 2 microglobulin has a renal handling compatible with that of an “ideal” marker of GFR. In fact, they are cleared by the plasma through free glomerular filtration, subsequent complete tubular resorption, and degradation inside tubular cells.

Keywords:

B2 Microglobulin, Serum creatinine, Creatinine clearance, Renal function.

References:

  1. Aksun S Appakan, Ozmen D, Ozmen B. Beta2-Microglobulin and cystatin C in type 2 diabetes:assessment of diabetic nephropathy.German society of Endocrinology and Diabetes association 2004; 112:195-200.
  2. Cheung AK, Rocco MV, Yan G. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol 2006; 17:546-55.
  3. Donadio C, Lucchesi A, Ardini M, Giordani R. Cystatin C, β2-microglobulin, and retinol binding protein as indicators of glomerular filtration rate: comparison with plasma creatinine. J Pharm Biomed Anal 2001; 24:835-42.
  4. Donadio C, Lucchesi A, Ardini M. Cystatin C, β2-microglobulin, and retinol binding protein as indicators of glomerular filtration rate: comparison with plasma creatinine. J Pharm Biomed Anal 2001; 24:835-42.
  5. Donadio C, Lucchesi A, Tramonti G. Creatinine clearance predicted from body cell mass is a good indicator of renal function. Kidney Int 1997; 52(63):166-8.
  6. Drueke TB, Massy ZA. Beta2-microglobulin. Semin Dial 2009; 22:378-80.
  7. Jafar TH, Schmid CH, Levey AS, Serum creatinine as marker of kidney functions in South Asians. J Am Soc Nephrol 2005; 16:1413-9.
  8. Jovanović D, Krstivojević P, Obradović I, Durdević V, Dukanović L. Serum cystatin C and beta2-microglobulin as markers of glomerular filtration rate. Ren Fail 2003; 25:123–33.
  9. Liabeuf S, Lenglet A, Desjardins L, Neirynck N, Glorieux G, Lemke HD, et al. Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients. Kidney Int 2012; 82:1297–303.
  10. Middleton RJ, Foley RN, Hegarthy J. The unrecognized prevalence of chronic kidney disease in diabetes. Nephrol Dial Transplant 2006; 21:88-92.
  11. Pilotovich VS, Serdyuchenko NS, Arinchin VN. The role of beta-2-microglobulin in the diagnosis of nephrological diseases. Med J 2011; 1:80-3.
  12. Sateesh Pujari and Estari Mamidala (2015). Anti-diabetic activity of Physagulin-F isolated
    from Physalis angulata fruits. The Ame J Sci & Med Res, 2015,1(1):53-60...

Article Dates:

Received: 5 January 2017; Accepted: 24 February 2017; Published: 2 March 2017

How To Cite:

Rania Mohamed Farag, Hanaa Mahmoud Ali, Heba Seleem El-Shair, & Salah Saaed Naga. (2022). Plasma beta2 microglobulin as a marker of progression in chronic Kidney disease patients. Biolife, 5(1), 28–32. https://doi.org/10.5281/zenodo.7356471

Download Full Paper: PDF
Submit Manuscript
Join as Reviewer / Editor

Logo


Logo